Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Reactogenicity of H1N1 Challenge Virus in Healthy Volunteers
NCT04106817Phase 1Completed
- Sponsor
- WCCT Global
- Start
- Jan 2015
- Primary completion
- Aug 2015
01
Overview
Phase 1, open-label trial in influenza (3 cohorts), sponsored by WCCT Global. Primary endpoints: Viral Shedding at Day 9 and Seroconversion at Day 60. Started Jan 2015; status: completed.
02
Conditions
influenza
Beyond the preview
Go deeper on NCT04106817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04106817.